Fludarabine trials for Triple Negative Breast Cancer

All Fludarabine trials · All Triple Negative Breast Cancer trials

Phase breakdown

Recruiting trials studying Fludarabine for Triple Negative Breast Cancer

• GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
  NCT07297667 · Phase: Phase 1 · Ages: 15 Years and older · Sex: All (male and female) · 2 locations
• Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
  NCT06347068 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
  NCT04282044 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Fludarabine for Triple Negative Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.